• Home
  • Sitemap
  • Help
  • Technical Support
  • Contact
Granzymes / Related Products
You are here: Product Lines > Inflammation > Granzymes / Related Products
Toolbar - View Selection
 
 Items 1-20 of 30 Page 1 of 2 Select Page: 1 2  >>  
ALX-200-602 Revised 16-Oct-07
Granzyme B (human)
Add to Clipboard
PRODUCT LINE Cell Death / Apoptosis / Autophagy
PRODUCT CATEGORY Granzymes
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-200-602-C010   10 µg 495.00 USD Add To Cart
Product Specification
MW: ~32kDa.
EC: 3.4.21.79
SOURCE/HOST: Isolated from IL-2 activated human lymphocytes [1]. Active enzyme.
CONCENTRATION: ~5.6mg/ml
FORMULATION: Liquid. In 150mM sodium chloride. Contains no preservatives.
BIOLOGICAL ACTIVITY: Using standard cell lines, 10µg is sufficient to kill 1x108 cells [2].
SPECIFIC ACTIVITY: ≥10U/µg protein. One unit is defined as the amount of enzyme that hydrolyzes 1nmol BAADT per min. (Prod. No. ALX-260-050) [1].
SHIPPING: SHIPPED ON BLUE ICE
SHORT TERM STORAGE: -20°C
LONG TERM STORAGE: -80°C
USE/STABILITY: Do not dilute below 1mg/ml. Dilute solutions should be used within 24 hours.
HANDLING: Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -20°C.
Product Images
Please click on thumbnails to enlarge.
Product Specific Literature References
[1] Rapid purification of cationic granule proteases: application to human granzymes: W.L. Hanna, et al.; Protein Purif. Exp. 4, 398 (1993) Abstract
[2] New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis: C.J. Froelich, et al.; J. Biol. Chem. 271, 29073 (1996) Abstract; Full Text
[3] Granzyme B binds to target cells mostly by charge and must be added at the same time as perforin to trigger apoptosis: L. Shi, et al.; J. Immunol. 174, 5456 (2005) Abstract
[4] Granzyme A induces a pro-inflammatory cytokine response and not cell death.: C. J. Froelich, et al.; Immunity Epub ahead of print, (2007)
General Information
BACKGROUND/TECHNICAL INFORMATION Swiss-Prot link P10144: Granzyme B (human) (precursor)
Further Categories Containing This Product:
Natural ProteinsEnzymes
 
 
ALX-200-604/1 Revised 04-Jun-08
Perforin (human)
Add to Clipboard
SYNONYMS Lymphocyte Pore Forming Protein (human)
PFP (human)
Cytolysin (human)
PRODUCT LINE Cell Death / Apoptosis / Autophagy
PRODUCT CATEGORY Perforin / Related Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-200-604/1-C001   1 µg 450.00 USD Add To Cart
Product Specification
MW: ~70kDa
SOURCE/HOST: Human cytotoxic granules of YT cells.
CONCENTRATION:  
PURITY DETAIL: Purified by solubilization in 1M sodium chloride (sodium acetate buffer) followed by hydrophobic interaction chromatography.
FORMULATION: Liquid. In 150mM NaCl containing stabilizer.
SPECIFIC ACTIVITY: 5-10PU (permeabilizing units) (Jurkat)/µg protein. One PU is defined as the amount of perforin (ng) that produces 50% PI-positive cells in the sample.
SHIPPING: SHIPPED ON DRY ICE
LONG TERM STORAGE: -80°C
USE/STABILITY:

The stock solution may be diluted 10-fold with the provided dilution buffer. Prepare aliquots and store at -80°C. Diluted aliquots are stable for up to 3 months when stored at -80°C and for ~12 hours when stored at +4°C.

HANDLING: Avoid freeze/thaw cycles. For maximum product recovery after thawing, centrifuge the vial before opening the cap.
Product Specific Literature References
Granzyme B binds to target cells mostly by charge and must be added at the same time as perforin to trigger apoptosis: L. Shi, et al.; J. Immunol. 174, 5456 (2005) Abstract
General Information
BACKGROUND/TECHNICAL INFORMATION

Swiss-Prot link P14222: Perforin 1 (human) (precursor)

General Note:

Both primary and transformed lines are permeabilized by the perforin, but the concentration required to produce 50% permeabilized cells varies substantially according to cell type (e.g. lymphoid, epithelial, mesenchymal), sensitivity of the cell line and whether cells are suspended or adherent. Generally, consumption of perforin is greater in the testing of adherent cells due to non-specific binding of the pore-forming protein to the microwells. Perforin should be pre-titrated against the desired cell line to identify the minimal permeabilizing concentration for protein delivery (see below). This concentration will allow effective delivery of the protein without producing excessive background necrosis and represent the nanograms that achieve less than 10-20% permeabilization of the target cell in question.

Supplied with Perforin Dilution Buffer (1ml).


Protocol for Intracellular Perforin Mediated Protein Delivery

a. Materials Needed:
- Microfuge tubes (1.5ml)
- Calcium stock solution: 100mM CaCl2 in water.
- Ca2+-HEPES buffer: 20mM HEPES containing 150mM NaCl and 2.5mM CaCl2, pH 7.4
- BSA-HEPES buffer: 1% BSA solubilized in HEPES buffer (without Ca2+).
- Fatty acid-free BSA.
- Perforin Dilution Buffer (included).

b. Pre-titration of PFN against Desired Cells:
Immediately before the planned experiment, perforin should be titrated to identify concentration that minimally permeabilizes targets. Incubate desired cells with increasing concentrations of perforin for 15 min., then determine percentage of cells that have undergone permeabilization by Trypan Blue or Propidium Iodide stain.
1) Wash cells twice in Ca2+-HEPES buffer to remove serum from cell mixture and re-suspend at density
    of 1x106 per 50µl in same buffer.
2) For each sample, dilute perforin to twice the desired final concentration in 50µl of HEPES/1% BSA
    buffer to microfuge tubes.
3) Add 50µl of media control or dilute perforin to 50µl of cells in microfuge tubes.
4) Incubate at 37°C for 15 min.; periodic mixing is not required.
5) Perform readout to assess permeabilization.

d. Experimental Protocol:
1) Wash cells twice in Ca2+-HEPES buffer to remove serum from cell mixture and re-suspend at density
    of 1x106 per 50µl in same buffer.
2) Add Granzyme B (Prod. No. ALX-200-602) (1µg/ml); generally 1-2µl of stock is sufficient.
3) For desired samples, dilute perforin to twice the desired final concentration in 50µl of HEPES/1% BSA
    buffer to microfuge tubes.
4) Add 50µl of media control or dilute perforin to 50µl of cells in microfuge tubes.
5) Incubate at 37°C for desired time; periodic mixing is not required.
6) After incubation perform readout to assess permeabilization.

Further Categories Containing This Product:
Natural Proteins
 
 
ALX-200-605 Revised 23-Apr-05
Granzyme A (human)
Add to Clipboard
PRODUCT LINE Cell Death / Apoptosis / Autophagy
PRODUCT CATEGORY Granzymes
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-200-605-C010   10 µg 460.00 USD Add To Cart
Product Specification
MW: ~52kDa (fully glycosylated homodimer)
EC: 3.4.21.78
SOURCE/HOST: Human cytotoxic granules of NK-92 cells.
CONCENTRATION: 2.76mg/ml
PURITY DETAIL: Purified by differential solubilization and cation exchange chromatography. Dialyzed against 0.15M sodium chloride and concentrated.
FORMULATION: Liquid. In ~0.15M sodium chloride.
SPECIFIC ACTIVITY: ~9.2U/µg protein. One unit is defined as the amount of enzyme that hydrolyzes 1nmole of Z-Lys-SBzl per min. at 25°C in 0.05M TRIS, pH 8.0, containing 0.15M NaCl, 0.01% Triton X-100, 0.3mM DTNB.
SHIPPING: SHIPPED ON DRY ICE
LONG TERM STORAGE: -80°C
USE/STABILITY: Stable for at least 6 months when stored at -80°C. Do not store dilute solutions (1-1000ng/ml) for more than 24 hours.
HANDLING: Avoid freeze/thaw cycles. For maximum product recovery after thawing, centrifuge the vial before opening the cap. After opening, prepare aliquots and store at -80°C.
Product Specific Literature References
Granzyme A induces caspase-independent mitochondrial damage, a required first step for apoptosis: D. Martinvalet, et al.; Immunity 22, 355 (2005) Abstract
General Information
BACKGROUND/TECHNICAL INFORMATION Swiss-Prot link P12544: Granzyme A (human) (precursor)
Further Categories Containing This Product:
EnzymesNatural Proteins
 
 
ALX-201-112 Revised 18-Mar-08
Granzyme B (human) (recombinant)
Add to Clipboard
PRODUCT LINE Cell Death / Apoptosis / Autophagy
PRODUCT CATEGORY Granzymes
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-201-112-C010   10 µg 310.00 USD Add To Cart
Product Specification
MW: ~25.5kDa.
EC: 3.4.21.79
SOURCE/HOST: Produced in E. coli. Active human granzyme B.
CONCENTRATION: 0.2mg/ml
FORMULATION: Liquid. In PBS containing 10% glycerol. Contains no preservatives.
SPECIFIC ACTIVITY: ≥7.0U/µg protein. One unit is defined as the amount of enzyme that hydrolyzes 1nmol Ac-IEPD-pNA (Prod. No. ALX-260-152) per min. at 25°C in 0.05M TRIS, pH 8.0, containing 0.15M NaCl and 0.01% Triton X-100.
SHIPPING: SHIPPED ON DRY ICE
LONG TERM STORAGE: -80°C
USE/STABILITY: Dilute solutions (e. g. 1-1000ng/ml) should be used within 24 hours.
HANDLING: For maximum product recovery after thawing, centrifuge the vial before opening the cap. Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -80°C.
Product Specific Literature References
Crystal structure of the caspase activator human granzyme B, a proteinase highly specific for an Asp-P1 residue: E. Estebanez-Perpina, et al.; Biol. Chem. 381, 1203 (2000) Abstract
General Information
BACKGROUND/TECHNICAL INFORMATION Swiss-Prot link P10144: Granzyme B (human) (precursor)
General Literature References
Definition and redesign of the extended substrate specificity of granzyme B  : J.L. Harris, et al.; J. Biol. Chem. 273, 27364 (1998) Abstract; Full Text
Generation of catalytically active granzyme K from Escherichia coli inclusion bodies and identification of efficient granzyme K inhibitors in human plasma  : E. Wilharm, et al.; J. Biol. Chem. 274, 27331 (1999) Abstract; Full Text
Further Categories Containing This Product:
EnzymesRecombinant Proteins / Fusion Proteins
 
 
ALX-201-117 Revised 13-Dec-04
Granzyme K (human) (recombinant)
Add to Clipboard
PRODUCT LINE Cell Death / Apoptosis / Autophagy
PRODUCT CATEGORY Granzymes
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-201-117-C010   10 µg 310.00 USD Add To Cart
Product Specification
MW: ~26kDa.
EC: 3.4.21.-
SOURCE/HOST: Produced in E. coli. Active human granzyme K.
CONCENTRATION: 0.2mg/ml
FORMULATION: Liquid. Recombinant protein in PBS containing glycerol. Does not contain any preservatives.
SPECIFIC ACTIVITY: ~29U/µg protein. One unit is defined as the amount of enzyme that hydrolyzes 1nmol Z-Lys-SBzl per min. at 25°C in 0.05M TRIS, pH 8.0, containing 0.15M NaCl, 0.01% Triton X-100 and 0.3mM DTNB.
SHIPPING: SHIPPED ON DRY ICE
LONG TERM STORAGE: -80°C
USE/STABILITY: Stable for at least 6 months when stored at -80°C. Dilute solutions (e. g. 1-1000ng/ml) should be used within 24 hours.
HANDLING: For maximum product recovery after thawing, centrifuge the vial before opening the cap. After opening, prepare aliquots and store at -80°C.
Product Specific Literature References
Generation of catalytically active granzyme K from Escherichia coli inclusion bodies and identification of efficient granzyme K inhibitors in human plasma: E. Wilharm, et al.; J. Biol. Chem. 274, 27331 (1999) Abstract; Full Text
General Information
BACKGROUND/TECHNICAL INFORMATION Swiss-Prot link P49863: Granzyme K (human) (precursor)
Further Categories Containing This Product:
EnzymesRecombinant Proteins / Fusion Proteins
 
 
ALX-201-118 Revised 23-May-07
Granzyme A (human) (recombinant)
Add to Clipboard
PRODUCT LINE Cell Death / Apoptosis / Autophagy
PRODUCT CATEGORY Granzymes
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-201-118-C010   10 µg 310.00 USD Add To Cart
Product Specification
MW: ~52kDa (homodimer).
EC: 3.4.21.78
SOURCE/HOST: Produced in E. coli. Active human granzyme A.
CONCENTRATION: 0.2mg/ml.
FORMULATION: Liquid. In 0.05M MES, pH 6.0, containing 10% glycerol and ~0.52M sodium chloride. Contains no preservatives.
SPECIFIC ACTIVITY: ~110U/µg protein. One unit is defined as the amount of enzyme that hydrolyzes 1nmol Z-Lys-SBzl per min. at 25°C in 0.05M TRIS, pH 8.0, containing 0.15M NaCl, 0.01% Triton X-100 and 0.3mM DTNB.
SHIPPING: SHIPPED ON DRY ICE
LONG TERM STORAGE: -80°C
USE/STABILITY: Stable for at least 6 months after receipt when stored at -80°C. Do not dilute to more than 0.2mg/ml. Do not store dilute solutions (1-1000ng/ml) for more than 24 hours.
HANDLING: Avoid freeze/thaw cycles. For maximum product recovery after thawing, centrifuge the vial before opening the cap. After opening, prepare aliquots and store at -80°C.
General Information
BACKGROUND/TECHNICAL INFORMATION Swiss-Prot link P12544: Granzyme A (human) (precursor)
Further Categories Containing This Product:
EnzymesRecombinant Proteins / Fusion Proteins
 
 
ALX-210-917 Revised 02-Nov-06
Polyclonal Antibody to SET (human)
Add to Clipboard
SYNONYMS anti-PHAPII (human) PAb
anti-I2αPP2A (human) PAb
anti-Phosphatase 2A Inhibitor Protein 2α (human) PAb
anti-HLA-DR-associated Protein 2 (human) PAb
anti-IGAAD (human) PAb
anti-Inhibitor of Granzyme-activated DNase (human) PAb
anti-TAF-Iβ (human) PAb
anti-Template-activating Factor Iβ (human) PAb
PRODUCT LINE Signal Transduction
PRODUCT CATEGORY PP2A / Related Products
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-210-917-C050   50 µg 194.00 USD Add To Cart
Product Specification
SPECIES CROSSREACTIVITY:
Human
SOURCE/HOST: From rabbit.
CONCENTRATION: 1mg/ml
PURITY DETAIL: Protein A affinity-purified.
FORMULATION: Liquid. In PBS containing 0.02% sodium azide.
IMMUNOGEN: Synthetic peptide corresponding to aa 3-16 (A3PAAKVSKKELNSN16) of human SETβ.
SPECIFICITY: Recognizes human SETβ. Detects endogenous protein by IP and WB.
APPLICATION: Flow cytometry (1:100-1:200);
Immunocytochemistry;
Immunoprecipitation;
Western blot (1:1'000).
SHIPPING: SHIPPED ON BLUE ICE
SHORT TERM STORAGE: +4°C
LONG TERM STORAGE: -20°C
USE/STABILITY: Stable for at least one year after receipt if stored at -20°C.
HANDLING: Avoid freeze/thaw cycles.
Product Specific Literature References
Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks: P.J. Beresford, et al.; J. Biol. Chem. 276, 43285 (2001) Abstract; Full Text
HMG2 interacts with the nucleosome assembly protein SET and is a target of the cytotoxic T-lymphocyte protease granzyme A: Z. Fan, et al.; Mol. Cell. Biol. 22, 2810 (2002) Abstract; Full Text
Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A: Z. Fan, et al.; Nat. Immunol. 4, 145 (2003) Abstract
Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor: Z. Fan, et al.; Cell 112, 659 (2003) Abstract
Granzyme a induces caspase-independent mitochondrial damage, a required first step for apoptosis: D. Martinvalet, et al.; Immunity 22, 355 (2005) Abstract
General Information
MANUFACTURER Manufactured by Apotech Corporation.
Further Categories Containing This Product:
Granzymes Other ProductsPolyclonal Antibodies
 
 
ALX-260-042 Revised 02-Oct-07
Ac-IETD-AMC
Add to Clipboard
SYNONYMS Caspase-8 Substrate (Fluorogenic)
Granzyme B Substrate (Fluorogenic)
PRODUCT LINE Cell Death / Apoptosis / Autophagy
PRODUCT CATEGORY Caspase Substrates
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-260-042-M001   1 mg 42.00 USD Add To Cart
ALX-260-042-M005   5 mg 163.00 USD Add To Cart
Product Specification
SEQUENCE: Ac-Ile-Glu-Thr-Asp-AMC (AMC=7-Amino-4-methylcoumarin)
FORMULA: C31H41N5O12
MW: 675.7
PEPTIDE CONTENT: 70-90%
PURITY: ≥98% (HPLC)
FORMULATION: Lyophilized.
SOLUBILITY: Soluble in DMSO. Dilute with buffer, pH 7.5.
SHIPPING: AMBIENT
LONG TERM STORAGE: -20°C
Product Description
Fluorogenic substrate for caspase-8 and granzyme B. Also a substrate for caspase-10.
Product Specific Literature References
Bid truncation, bid/bax targeting to the mitochondria, and caspase activation associated with neutrophil apoptosis are inhibited by granulocyte colony-stimulating factor: N.A. Maianski, et al.; J. Immunol. 172, 7024 (2004) Abstract
General Information
BACKGROUND/TECHNICAL INFORMATION AMC has an excitation maximum of 380nm and an emission maximum of 460nm.
Further Categories Containing This Product:
Granzyme Substrates
 
 
ALX-260-043 Revised 13-Nov-06
Ac-IETD-CHO
Add to Clipboard
SYNONYMS Caspase-8 Inhibitor (Aldehyde)
Granzyme B Inhibitor (Aldehyde)
PRODUCT LINE Cell Death / Apoptosis / Autophagy
PRODUCT CATEGORY Caspase Inhibitors
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-260-043-M001   1 mg 62.00 USD Add To Cart
ALX-260-043-M005   5 mg 243.00 USD Add To Cart
Product Specification
SEQUENCE: Ac-Ile-Glu-Thr-Asp-CHO
FORMULA: C21H34N4O10
MW: 502.5
PEPTIDE CONTENT: 70-90%.
PURITY: ≥97% (HPLC)
FORMULATION: Lyophilized.
SOLUBILITY: Soluble in DMSO. Dilute with buffer, pH 7.5.
SHIPPING: AMBIENT
LONG TERM STORAGE: -20°C
USE/STABILITY: Use always fresh solutions.
HANDLING: Keep cool and dry.
Product Description
Reversible inhibitor of caspase-8 and granzyme B. Also inhibits caspase-10.
Product Specific Literature References
A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro: Z. Han, et al.; J. Biol. Chem. 272, 13432 (1997) Abstract; Full Text
Further Categories Containing This Product:
Granzyme Inhibitors
 
 
ALX-260-044 Revised 05-Apr-05
Z-IETD-pNA
Add to Clipboard
SYNONYMS Caspase-8 Substrate (Chromogenic)
Granzyme B Substrate (Chromogenic)
PRODUCT LINE Cell Death / Apoptosis / Autophagy
PRODUCT CATEGORY Caspase Substrates
Ordering Information
Product Numbers: Format: Size: Unit Price: Quantity: Add To Cart
ALX-260-044-M001   1 mg 22.00 USD Add To Cart
ALX-260-044-M005   5 mg 83.00 USD Add To Cart
Product Specification
SEQUENCE: Z-Ile-Glu-Thr-Asp-pNA (pNA = p-Nitroaniline)
FORMULA: C33H42N6O13
MW: 730.7
PEPTIDE CONTENT: 70-90%
PURITY: ≥99% (HPLC)
APPEARANCE: White powder.
FORMULATION: Lyophilized.
SOLUBILITY: Soluble in water.
SHIPPING: AMBIENT
LONG TERM STORAGE: -20°C
HANDLING: Keep cool and dry.
Product Description
Fluorogenic substrate for caspase-8 and granzyme B with increased cell permeability. Also substrate for caspase-10.
General Information
BACKGROUND/TECHNICAL INFORMATION λmax of pNA is 400nm.
Further Categories Containing This Product: